Characteristics of children enrolled in treatment trials for NF1-related plexiform neurofibromas

A Kim, A Gillespie, E Dombi, A Goodwin, W Goodspeed, E Fox, F M Balis, B C Widemann, A Kim, A Gillespie, E Dombi, A Goodwin, W Goodspeed, E Fox, F M Balis, B C Widemann

Abstract

Objective: To describe the characteristics of children enrolled in treatment trials for neurofibromatosis type 1 (NF1)-related plexiform neurofibroma (PN), PN tumor burden, PN-related complications, and treatment outcomes and to highlight the differences between characteristics of children with NF1 vs children with cancers entered on early phase drug trials.

Methods: Pre-enrollment characteristics and complications of PN were retrospectively analyzed in a cohort of 59 children with NF1-related PN treated on 1 of 7 clinical trials at the NIH between 1996 and 2007. Outcome was analyzed in a subset of 19 patients enrolled in phase I trials. Comparisons to children with cancer were made from a similar analysis performed recently.

Results: The median age at enrollment was 8 years. The median PN volume was 555 mL. Most patients had no prior chemotherapy or radiation, but nearly half had previous surgery for PN. PN-associated complications and NF1 manifestations were common, including pain (53%), other tumors (18%), and hypertension (8%). Investigational drug therapy was well tolerated. A median of 10 treatment cycles was administered. Patients with NF1-related PN were younger, had better performance score, had less prior therapy, and remained on study longer than cancer patients.

Conclusions: Children with NF1-related plexiform neurofibroma (PN) enrolled in clinical trials had large tumors with substantial morbidity. Clinical trials in these children provide information about drug tolerance, cumulative toxicity, and pharmacokinetics in a younger population than early phase pediatric cancer trials. This report may aid in the evaluation of the applicability of traditional pediatric cancer trial designs and endpoints for NF1-related PN.

Figures

https://www.ncbi.nlm.nih.gov/pmc/articles/instance/2764415/bin/znl0400970240001.jpg
Figure Plexiform neurofibroma (PN) anatomic location A total of 87 PN were evaluated in 59 patients. A total of 23 patients had ≥2 PN. PN location: head (n = 6), head/neck (n = 8), neck/trunk (n = 5), trunk (n = 35), trunk/extremities (n = 21), extremity only (n = 3).

Source: PubMed

3
Se inscrever